Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Is intensity the solution for FMT in ulcerative colitis?

Inflammatory bowel diseases have been associated with a profound decrease in microbial diversity.1 Since the report by Turnbaugh and colleagues,2 in which the phenotype of a mouse was changed by faecal microbiota transfer (FMT), it became tempting to speculate that intestinal inflammation might be cured by this strategy. This idea has been proved by findings of a randomised trial in patients with Clostridium difficile colitis,3 whereby one FMT enema induced resolution of C difficile-associated diarrhoea in 81% (13 of 16) of patients.